PTGX
Price
$58.12
Change
-$3.31 (-5.39%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
3.62B
69 days until earnings call
VRAX
Price
$0.61
Change
+$0.02 (+3.39%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
2.67M
Interact to see
Advertisement

PTGX vs VRAX

Header iconPTGX vs VRAX Comparison
Open Charts PTGX vs VRAXBanner chart's image
Protagonist Therapeutics
Price$58.12
Change-$3.31 (-5.39%)
Volume$14.73K
Capitalization3.62B
Virax Biolabs Group
Price$0.61
Change+$0.02 (+3.39%)
Volume$1.3K
Capitalization2.67M
PTGX vs VRAX Comparison Chart in %
Loading...
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTGX vs. VRAX commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTGX is a StrongBuy and VRAX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (PTGX: $61.43 vs. VRAX: $0.59)
Brand notoriety: PTGX and VRAX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTGX: 201% vs. VRAX: 120%
Market capitalization -- PTGX: $3.62B vs. VRAX: $2.67M
PTGX [@Biotechnology] is valued at $3.62B. VRAX’s [@Biotechnology] market capitalization is $2.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTGX’s FA Score shows that 1 FA rating(s) are green whileVRAX’s FA Score has 0 green FA rating(s).

  • PTGX’s FA Score: 1 green, 4 red.
  • VRAX’s FA Score: 0 green, 5 red.
According to our system of comparison, PTGX is a better buy in the long-term than VRAX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTGX’s TA Score shows that 5 TA indicator(s) are bullish while VRAX’s TA Score has 4 bullish TA indicator(s).

  • PTGX’s TA Score: 5 bullish, 4 bearish.
  • VRAX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PTGX is a better buy in the short-term than VRAX.

Price Growth

PTGX (@Biotechnology) experienced а +9.25% price change this week, while VRAX (@Biotechnology) price change was -22.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.10%. For the same industry, the average monthly price growth was +14.72%, and the average quarterly price growth was +30.35%.

Reported Earning Dates

PTGX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTGX($3.62B) has a higher market cap than VRAX($2.67M). PTGX YTD gains are higher at: 59.145 vs. VRAX (-73.564). PTGX has higher annual earnings (EBITDA): 26.8M vs. VRAX (-6.43M). PTGX has more cash in the bank: 570M vs. VRAX (7.29M). VRAX has less debt than PTGX: VRAX (380K) vs PTGX (11.3M). PTGX has higher revenues than VRAX: PTGX (209M) vs VRAX (84.9K).
PTGXVRAXPTGX / VRAX
Capitalization3.62B2.67M135,468%
EBITDA26.8M-6.43M-417%
Gain YTD59.145-73.564-80%
P/E Ratio79.64N/A-
Revenue209M84.9K246,172%
Total Cash570M7.29M7,823%
Total Debt11.3M380K2,974%
FUNDAMENTALS RATINGS
PTGX: Fundamental Ratings
PTGX
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
63
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
3
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PTGXVRAX
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
77%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PTGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRAX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRASX91.630.24
+0.26%
Janus Henderson Research S
HNCTX21.17N/A
N/A
Hartford International Growth R5
FCLKX17.62N/A
N/A
Fidelity Large Cap Stock K6
GSAKX20.00N/A
N/A
Goldman Sachs International Eq Inc A
WBENX14.03-0.04
-0.28%
William Blair Emerging Mkts Growth N

PTGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PTGX has been closely correlated with BIESF. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if PTGX jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTGX
1D Price
Change %
PTGX100%
+7.79%
BIESF - PTGX
66%
Closely correlated
N/A
MLYS - PTGX
52%
Loosely correlated
+0.66%
TRVI - PTGX
42%
Loosely correlated
+7.82%
DNLI - PTGX
41%
Loosely correlated
+0.32%
ORMP - PTGX
37%
Loosely correlated
+4.25%
More

VRAX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRAX has been loosely correlated with ALZN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if VRAX jumps, then ALZN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRAX
1D Price
Change %
VRAX100%
-6.08%
ALZN - VRAX
45%
Loosely correlated
+0.82%
GOVX - VRAX
34%
Loosely correlated
-3.21%
NTRB - VRAX
31%
Poorly correlated
-0.62%
PTGX - VRAX
30%
Poorly correlated
+7.79%
PYPD - VRAX
28%
Poorly correlated
N/A
More